ANTIPSORIATIC ACTIVITY OF HYDROGEL CONTAINING NANOSTRUCTURED LIPID CARRIER (NLC) ENTRAPPED WITH TRIAMCINOLONE ACETONIDE
DOI:
https://doi.org/10.22159/ijap.2023v15i1.46198Keywords:
Nanostructured lipid Carrier, Hydrogel, Antipsoriatic activity, Irritation study, Triamcinolone acetonideAbstract
Objective: The aim of present study was to prepare triamcinolone acetonide (TA) loaded NLCs hydrogel for antipsoriatic activity.
Methods: A Nanostructured lipid carrier (NLCs) was prepared by using solvent diffusion and high pressure homogenization methods. NLCs dispersion was characterized by particle size, zeta potential, scanning electron microscopy (SEM), differential scanning calorimetry, and an in vitro release study. Optimized NLC incorporated into the hydrogel and characterized for rheological properties, drug content, in vitro drug release, stability study, skin irritation and antipsoriatic activity for optimized batch of hydrogel.
Results: Optimized NLCs loaded with TA were exhibited spherical shape with particle size 286±0.07 nm, polydispersity index 0.317, zeta potential-21.91±0.05mV and entrapment efficiency 86.19±0.06% respectively. The drug release of optimized batch was 8.34 % and 88.84±0.08% at 1h and 8h respectively. The release kinetics of the optimized NLCs best fitted the peppas-korsmeyer model. The results of NLC hydrogel formulations were spreadability 27.4±0.06-11.76±0.07 g. cm2/sec, drug content 65.60±0.05%-74.50±0.02%, in vitro drug release 87.52±0.04%, primary irritation index was 0.0752, it indicates barely perceptible irritation. Histopathological studies showed that, in psoriasis-induced animal treated with TA loaded NLC hydrogel, marked reduction in thickness of epidermis, as compared to conventional gel formulation. It shows the increase % orthokeratosis 88.69% and % drug activity 54.23% than the marketed formulation.
Conclusion: The present results demonstrated that hydrogel based NLC shows the better and effective drug delivery for the management of psoriasis.
Downloads
References
Salunkhe SS, Bhatia NM, Bhatia MS. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Drug Deliv. 2016;23(4):1306-16. doi: 10.3109/10717544.2014.943337, PMID 25080227.
Carmona Ribeiro AM. Biomimetic nanoparticles: preparation, characterization and biomedical applications. Int J Nanomedicine. 2010;5:249-59. doi: 10.2147/ijn.s9035, PMID 20463941.
Kovacs SZ, Berko E, Csany I. Development of nanostructured lipid carriers containing salicylic acid for dermal use based on the quality by design method. Eur J Pharm Sci. 2016:4-5.
Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54Suppl 1:S131-55. doi: 10.1016/s0169-409x(02)00118-7, PMID 12460720.
Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1-2):170-84. doi: 10.1016/j.ijpharm.2008.10.003, PMID 18992314.
Patwekar SL, Pedewad SR, Gattani S. Development and evaluation of nanostructured lipid carriers-based gel of isotretinoin. Particulate Science and Technology 2018;36(7):832-43. doi: 10.1080/02726351.2017.1305026.
Müller RH, Rühl D, Runge S, Schulze Forster K, Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res. 1997;14(4):458-62. doi: 10.1023/a:1012043315093, PMID 9144731.
Panda R, Kuotsu K. Fabrication, characterization, and in vitro evaluation of pegylated glyceride labrasol nanostructured lipid carrier composite of methotrexate: the pathway to effective cancer therapy. Asian J Pharm Clin Res. 2019;12:29-37.
Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170(3):380-95. doi: 10.1016/j.jconrel.2013.05.020, PMID 23770117.
Coope H, Mckenna DJ, Alexandroff AB. Long term safety of biologics in the treatment of psoriasis. Psoriasis Targets Ther. 2013:1-9.
Knudsen NO, Jorgensen L, Hansen J, Vermehren C, Frokjaer S, Foged C. Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity. Int J Pharm. 2011;416(2):478-85. doi: 10.1016/j.ijpharm.2011.03.014, PMID 21419203.
Ryan C, Korman NJ, Gelfand JM, Lim HW, Elmets CA, Feldman SR. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol. 2014;70(1):146-67. doi: 10.1016/j.jaad.2013.08.042, PMID 24126079.
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(2)Suppl 2:3-11. doi: 10.1111/j.1468-3083.2011.04410.x, PMID 22356630.
Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta. 2004;1663(1-2):61-73. doi: 10.1016/j.bbamem.2004.01.006, PMID 15157608.
Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol. 2002;3(1):47-58. doi: 10.2165/00128071-200203010-00005, PMID 11817968.
Dixit CM, Akhil S, Mukundan S, Gupta S. Development and in vitro evaluation of nanolipid carrier of clobetasol propionate and Promaxine hydrochloride for topical delivery. Int J Appl Pharm. 2018;10:28-36.
Katare OP, Raza K, Singh B, Dogra S. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol. 2010;76(6):612-21. doi: 10.4103/0378-6323.72451, PMID 21079304.
Zhang YT, Shen LN, Wu ZH, Zhao JH, Feng NP. Evaluation of skin viability effect on ethosome and liposome-mediated psoralen delivery via cell uptake. J Pharm Sci. 2014;103(10):3120-6. doi: 10.1002/jps.24096, PMID 25070929.
Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 2005;45(3-4):167-73. doi: 10.1016/j.colsurfb.2005.08.005, PMID 16198092.
Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo‐controlled, double‐blind study. Trop Med Int Health. 1996;1(4):505-9. doi: 10.1046/j.1365-3156.1996.d01-91.x, PMID 8765459.
Potdar D, Hirwani RR, Dhulap S. Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia. 2012;83(5):817-30. doi: 10.1016/j.fitote.2012.04.012, PMID 22808523.
More B, Sakharwade S, Tembhurne S, Sakarkar D. Evaluation for skin irritancy testing of developed formulations containing extract of Butea monosperma for its topical application. Int J Toxicol Appl Pharmacol. 2013;3(1):10-3.
Zhang JQ, Liu J, Li XL, Jasti BR. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 2007;14(6):381-7. doi: 10.1080/10717540701203034, PMID 17701527.
Zou DN, Zhang DR, Zhou XH. HPLC determination of entrapment efficiency of matrine-loaded albumin nanoparticles. Chin J Pharm Anal 2008;28:93-6.
Sonawane R, Harde H, Katariya M, Agrawal S, Jain S. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv. 2014;11(12):1833-47. doi: 10.1517/17425247.2014.938634, PMID 25078031.
Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-90.
Lin YK, Yang SH, Chen CC, Kao HC, Fang JY. Using imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugs. PLOS ONE. 2015;10(9):e0137890. doi: 10.1371/journal.pone.0137890, PMID 26355594.
Qin ZM, Chen F, Chen DM, Wang Y, Tan Y, Ban J. Transdermal permeability of triamcinolone acetonide lipid nanoparticles. Int J Nanomedicine. 2019;14:2485-95. doi: 10.2147/IJN.S195769, PMID 31040670.
Sarfaraz A, Sajid A, Nawazish A, Intakhab A. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J Appl Pharm Sci. 2012;2(10):148-58. doi: 10.7324/JAPS.2012.21029.
Vijayalakshmi A, Ravichandiran V, Malarkodi V, Nirmala S, Jayakumari S. Screening of flavonoid “quercetin” from the rhizome of Smilax china Linn. for anti-psoriatic activity. Asian Pac J Trop Biomed. 2012;2(4):269-75. doi: 10.1016/S2221-1691(12)60021-5, PMID 23569912.
Skuric J, Orolic N, Kolaric D, Dikic D, Benkovic V. Effectivity of flavonoids on animal model psoriasis-thermographic evaluation. Period Biol. 2011;57:457-63.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Anilkumar Jalindar Shinde
This work is licensed under a Creative Commons Attribution 4.0 International License.
